30.1 C
New Delhi

Molnupiravir and Paxlovid , the heavily promoted antiviral drug ,Are they really safe ?

Date:

Share post:

So many new drugs come to the market and marketed as the panacea for the illness.
History reveals many such drugs had to be withdrawn due to toxicity.

If you have practiced medicine in the last 2 to 3 decades will remember many drugs that were withdrawn due to severe adverse effects.

Cisapride was used for heartburn,flatulence got withdrawn in 2003,it was shown to cause heart rhythm disturbances

Rofecoxib was a drug prescribed right and left for arthritic pain but later shown causing more heart attacks and thus withdrawn from the market.

This drug was marketed by Merck the same company promoting Molnupiravir the anti COVID pill which has been flagged up with problems specially to pregnant women and those planning to get pregnant

Terfenadine was used for allergy drug.It was withdrawn

Rosiglitazone an anti diabetic drug had 13,000 law suits as it was shown to cause more heart attacks.

When the modern Allopathy looks at Ayurveda as herbal medicine field,the reality is long list of medicines that were used heavily in allopathy but got withdrawn due to toxicities.

Why this post now?

Molnupiravir and Paxlovid two antiviral drugs promoted heavily for the COVID but we have to be cautious that no drug is safer and doctors should exercise caution in not going overboard to prescribe to everybody( an Indian phenomenon).

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

All India Ulema Board offers support to Maha Vikas Aghadi with few ‘Anti Hindu’ and ‘Anti constitution’ Conditions

Amid the high-decibel campaign for upcoming Maharashtra Assembly polls, a letter by the All India Ulema Board to...

Canada ends Student Direct Stream visa programme: How this move can impact Indian students

Amid an ongoing diplomatic standoff between India and Canada, Justin Trudeau's government suspended its popular Student Direct Stream...

What Trump’s Win means for India and the World

Donald Trump is poised to become only the second US president to secure a non-consecutive second term, following...

Massive Relief as India-China completed Disengagement at two friction points in Ladakh, stage set for patrolling resumption

Setting the stage for resumption of patrolling in the Depsang Plains and Demchok areas of eastern Ladakh, India...